Crystal structures of catalytic core domains of retroviral integrases and role of divalent cations in enzymatic activity
- PMID: 10384241
- DOI: 10.1016/s0065-3527(08)60305-x
Crystal structures of catalytic core domains of retroviral integrases and role of divalent cations in enzymatic activity
Abstract
Crystal structures of the enzymatically competent catalytic domains of HIV-1 and ASV IN have been solved in the last few years. The structure of HIV-1 IN has been described only for apoenzyme and for a complex with Mg2+, whereas the structure of ASV IN has been presented as the apoenzyme, in the presence of divalent cations (Mn2+, Mg2+, Ca2+, Zn2+, and Cd2+), and with an inhibitor. A single ion of Mn2+, Mg2+, or Ca2+ interacts with the two aspartate side chains of the D,D(35)E catalytic center in octahedral coordination with four water molecules. However, two ions of Zn2+ or Cd2+ bind to the active site of IN with tetrahedral and octahedral coordination, respectively. Only small adjustments take place in the active site of ASV IN on binding of the metal cofactor(s), which are absolutely required for the activity of this enzyme. The placement of the side chains and metal ions in the active site is very similar to that observed even in distant members of this superfamily of polynucleotidyltransferases. Here the role of divalent cations in the enzymatic activity of IN and the search for inhibitors of this enzyme are discussed.
Similar articles
-
The catalytic domain of avian sarcoma virus integrase: conformation of the active-site residues in the presence of divalent cations.Structure. 1996 Jan 15;4(1):89-96. doi: 10.1016/s0969-2126(96)00012-3. Structure. 1996. PMID: 8805516
-
Binding of different divalent cations to the active site of avian sarcoma virus integrase and their effects on enzymatic activity.J Biol Chem. 1997 Jul 18;272(29):18161-8. doi: 10.1074/jbc.272.29.18161. J Biol Chem. 1997. PMID: 9218451
-
Structure of the catalytic domain of avian sarcoma virus integrase with a bound HIV-1 integrase-targeted inhibitor.Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):4831-6. doi: 10.1073/pnas.95.9.4831. Proc Natl Acad Sci U S A. 1998. PMID: 9560188 Free PMC article.
-
Structure and function of retroviral integrase.Nat Rev Microbiol. 2022 Jan;20(1):20-34. doi: 10.1038/s41579-021-00586-9. Epub 2021 Jul 9. Nat Rev Microbiol. 2022. PMID: 34244677 Free PMC article. Review.
-
HIV-1 integrase: the next target for AIDS therapy?Pathol Biol (Paris). 2001 Apr;49(3):237-46. doi: 10.1016/s0369-8114(01)00135-3. Pathol Biol (Paris). 2001. PMID: 11367559 Review.
Cited by
-
Inhibition of human immunodeficiency virus type 1 reverse transcriptase, RNase H, and integrase activities by hydroxytropolones.Antimicrob Agents Chemother. 2005 Dec;49(12):4884-94. doi: 10.1128/AAC.49.12.4884-4894.2005. Antimicrob Agents Chemother. 2005. PMID: 16304149 Free PMC article.
-
HIV integrase inhibitor, Elvitegravir, impairs RAG functions and inhibits V(D)J recombination.Cell Death Dis. 2017 Jun 1;8(6):e2852. doi: 10.1038/cddis.2017.237. Cell Death Dis. 2017. PMID: 28569776 Free PMC article.
-
Diketo acid inhibitor mechanism and HIV-1 integrase: implications for metal binding in the active site of phosphotransferase enzymes.Proc Natl Acad Sci U S A. 2002 May 14;99(10):6661-6. doi: 10.1073/pnas.092056199. Epub 2002 May 7. Proc Natl Acad Sci U S A. 2002. PMID: 11997448 Free PMC article.
-
Integration by design.Proc Natl Acad Sci U S A. 2003 May 13;100(10):5586-8. doi: 10.1073/pnas.1031802100. Epub 2003 May 5. Proc Natl Acad Sci U S A. 2003. PMID: 12732725 Free PMC article. Review. No abstract available.
-
Molecular dynamics studies of the wild-type and double mutant HIV-1 integrase complexed with the 5CITEP inhibitor: mechanism for inhibition and drug resistance.Biophys J. 2003 Mar;84(3):1450-63. doi: 10.1016/S0006-3495(03)74958-3. Biophys J. 2003. PMID: 12609852 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous